Mesoblast (MEOBF) EBT (2014 - 2023)

Mesoblast has disclosed EBT across 10 years of filings, most recently posting -$22.0 million for Q2 2023.

• In Q2 2023, EBT fell 113.58% year-over-year to -$22.0 million; the TTM figure through Jun 2023 stood at -$82.1 million (down 189.64% YoY), while the FY2026 annual figure was $56.9 million, down 44.13% from the prior year.
• EBT came in at -$22.0 million for Q2 2023 at Mesoblast, down from -$18.6 million in the prior quarter.
• In the past five years, EBT ranged from a high of $177.1 million in Q2 2021 to a low of -$51.5 million in Q1 2020.
• Average EBT over 5 years is -$2.1 million, with a median of -$23.9 million recorded in 2019.
• Year-over-year, EBT jumped 63.3% in 2019 and sank 240.8% in 2020.
• Over 5 years, EBT stood at -$34.3 million in 2019, then increased by 25.24% to -$25.6 million in 2020, then slipped by 1.59% to -$26.0 million in 2021, then increased by 5.64% to -$24.6 million in 2022, then climbed by 10.58% to -$22.0 million in 2023.
• Per Business Quant data, the three most recent EBT figures were -$22.0 million in Q2 2023, -$18.6 million in Q1 2023, and -$24.6 million in Q4 2022.